Barclays PLC Omeros Corp Put Options Transaction History

Barclays PLC

4 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2019 Feb 10, 2020	BUY	$13.01 - $17.15 $5,204 - $6,859	400 Added 66.67%	1,000 $14,000
Q3 2018 Nov 14, 2018	SELL	$17.73 - $26.69 $8,865 - $13,345	-500 Reduced 45.45%	600 $15,000
Q2 2018 Aug 14, 2018	SELL	$10.79 - $24.44 $7,552 - $17,108	-700 Reduced 38.89%	1,100 $20,000
Q1 2018 May 15, 2018	BUY	$9.0 - $20.16 $16,200 - $36,288	1,800 New	1,800 $20,000

121

25.6M

228K

630K

Ticker OMER
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,730,000
Market Cap $555M
Description
Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

Stay updated on Barclays PLC with notifications on news.